South African study: Johnson & Johnson COVID-19 vaccine booster injection can be effective against Omicron

A study in South Africa showed that Johnson & Johnson's COVID-19 vaccine boosters could reduce hospitalization rates for patients infected with the Amicoren strain by 84 percent. A lead researcher said that the results of this experiment prove that even if a new mutation occurs in the new crown virus, the protective effect of existing vaccines still exists.

Experimental data show that the effectiveness of the reinforcing needle increases over time. Hospitalization rates decreased by 63 per cent within a few days of intensive vaccination; this figure increased to 84 per cent after 14 days of vaccination; and the preventive effect reached 85 per cent after one to two months of vaccination.

Although the data showed that Johnson & Johnson's first dose of vaccine was less effective against the Olmikron strain, its booster needle was still effective in preventing the onset of severe diseases. In addition, Johnson & Johnson vaccine has better heat resistance than Pfizer's two doses of COVID-19 vaccine. As a result, it is more suitable for being transported to remote rural African areas.

South African study: Johnson & Johnson COVID-19 vaccine booster injection can be effective against Omicron. Click on the video to see for yourself!